> You cannot release this life saving technology because it has a 'disparate impact' on group B relative to group A.
Who is preventing you in this imagined scenario?
There are drugs that are more effective on certain groups of people than others. BiDil, for example, is an FDA approved drug marketed to a single racial-ethnic group, African Americans, in the treatment of congestive heart failure. As long as the risks are understood there can be accommodations made ("this AI tool is for males only" etc). However such limitations and restrictions are rarely mentioned or understood by AI hype people.
What does this have to do with FDA or drugs? Re-read the comment I was replying to. It's complaining that a technology could serve one group of people better than another, and I would argue that this should not be our goal.
A technology should be judged by "does it provide value to any group or harm any other group". But endlessly dividing people into groups and saying how everything is unfair because it benefits group A over group B due to the nature of the problem, just results in endless hand-wringing and conservatism and delays useful technology from being released due to the fear of mean headlines like this.